R N Foley

Summary

Publications

  1. ncbi request reprint Long-term evolution of cardiomyopathy in dialysis patients
    R N Foley
    Divisions of Nephrology and Clinical Epidemiology, Memorial University, Newfoundland, Montreal, Quebec, Canada
    Kidney Int 54:1720-5. 1998
  2. ncbi request reprint Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
    R N Foley
    The Health Sciences Center, Memorial University of Newfoundland, Saint John s, UK
    Kidney Int 58:1325-35. 2000
  3. ncbi request reprint Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study
    Robert N Foley
    Cardiovascular Special Studies Center, United States Renal Data System, Minneapolis, Minnesota, USA
    Kidney Int 62:1784-90. 2002
  4. ncbi request reprint Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease
    R N Foley
    Divisions of Nephrology and Clinical Epidemiology, Memorial University, St John s, Newfoundland, Canada
    J Am Soc Nephrol 11:912-6. 2000
  5. ncbi request reprint Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants
    C A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 71:425-30. 2007
  6. ncbi request reprint Cardiovascular disease and mortality in ESRD
    R N Foley
    The Division of Nephrology, The Health Sciences Centre, Memorial University, St John s, Newfoundland, Canada
    J Nephrol 11:239-45. 1998
  7. ncbi request reprint Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study
    Y Slinin
    United States Renal Data System Coordinating Center, Minneapolis, Minnesota, USA
    Kidney Int 70:1135-41. 2006
  8. ncbi request reprint Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study
    Areef Ishani
    Section of Nephrology, Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Kidney Int 68:311-8. 2005
  9. ncbi request reprint The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
    Edward F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    Kidney Int 66:2389-401. 2004
  10. ncbi request reprint Hypertension is harmful to dialysis patients and should be controlled
    Robert N Foley
    Chronic Disease Research Group and University of Minnesota, Minneapolis, Minnesota, USA
    Semin Dial 20:518-22. 2007

Collaborators

Detail Information

Publications57

  1. ncbi request reprint Long-term evolution of cardiomyopathy in dialysis patients
    R N Foley
    Divisions of Nephrology and Clinical Epidemiology, Memorial University, Newfoundland, Montreal, Quebec, Canada
    Kidney Int 54:1720-5. 1998
    ..METHODS; Baseline and yearly echocardiograms were performed in a prospective inception cohort of 433 dialysis patients. The mean patient follow-up was 41 months; 29 patients had four consecutive echocardiograms at yearly intervals...
  2. ncbi request reprint Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
    R N Foley
    The Health Sciences Center, Memorial University of Newfoundland, Saint John s, UK
    Kidney Int 58:1325-35. 2000
    ..The benefits and risks of normalizing hemoglobin levels in hemodialysis patients without symptomatic cardiac disease are unknown...
  3. ncbi request reprint Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study
    Robert N Foley
    Cardiovascular Special Studies Center, United States Renal Data System, Minneapolis, Minnesota, USA
    Kidney Int 62:1784-90. 2002
    ..The long-term prognostic associations of pre- and post-dialysis blood pressures, interdialytic weight gain, and antihypertensive use in hemodialysis patients are unclear...
  4. ncbi request reprint Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease
    R N Foley
    Divisions of Nephrology and Clinical Epidemiology, Memorial University, St John s, Newfoundland, Canada
    J Am Soc Nephrol 11:912-6. 2000
    ..Regression of LV abnormalities is associated with an improved cardiac outcome in dialysis patients. Serial echocardiography adds prognostic information to one performed at baseline...
  5. ncbi request reprint Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants
    C A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 71:425-30. 2007
    ....
  6. ncbi request reprint Cardiovascular disease and mortality in ESRD
    R N Foley
    The Division of Nephrology, The Health Sciences Centre, Memorial University, St John s, Newfoundland, Canada
    J Nephrol 11:239-45. 1998
    ..Many risk factors act in concert to produce cardiovascular disease in ESRD. Many can be treated, suggesting that the huge burden of disease can be reduced considerably...
  7. ncbi request reprint Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study
    Y Slinin
    United States Renal Data System Coordinating Center, Minneapolis, Minnesota, USA
    Kidney Int 70:1135-41. 2006
    ..04 (95% CI 2.58-3.66) for 6- to 12-months, and 2.31 (95% CI 1.97-2.71) for 12-18 months, and remained approximately twofold thereafter. Hospitalization with pneumonia is common in hemodialysis patients and carries a poor prognosis...
  8. ncbi request reprint Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study
    Areef Ishani
    Section of Nephrology, Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Kidney Int 68:311-8. 2005
    ..It is logical to postulate that septicemia, a common macroinflammatory occurrence in dialysis patients, contributes to their large burden of cardiovascular disease...
  9. ncbi request reprint The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
    Edward F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    Kidney Int 66:2389-401. 2004
    ..This study was undertaken to identify key patient characteristics for which the risk of death differs by dialysis modality...
  10. ncbi request reprint Hypertension is harmful to dialysis patients and should be controlled
    Robert N Foley
    Chronic Disease Research Group and University of Minnesota, Minneapolis, Minnesota, USA
    Semin Dial 20:518-22. 2007
    ..As dialysis patients are at vast cardiovascular risk, these findings suggest that aggressive treatment of hypertension should be the default approach, until large clinical trials show otherwise...
  11. ncbi request reprint Clinical epidemiology of long-bone fractures in patients receiving hemodialysis
    Thomas M Kaneko
    Department of Neurosurgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
    Clin Orthop Relat Res 457:188-93. 2007
    ..Long-bone fractures are common in patients receiving dialysis; their adverse prognostic implications may be linked to major cardiovascular and infectious events...
  12. ncbi request reprint The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 16:210-8. 2005
    ..Parathyroidectomy rates in U.S. hemodialysis patients increased between 1998 and 2002, a period in which the therapeutic armamentarium for preventing severe hyperparathyroidism expanded considerably...
  13. ncbi request reprint Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:489-95. 2005
    ..On an absolute basis, however, the high death rates of patients with CKD may reflect accelerated rates of atherosclerotic vascular disease and congestive heart failure...
  14. ncbi request reprint Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study
    Yelena Slinin
    University of Minnesota, Minneapolis, Minnesota, USA
    Hemodial Int 11:62-71. 2007
    ..Younger patients on long-term hemodialysis may be at a special risk. Parathyroidectomy risk increases stepwise with alterations in bone metabolism variables, suggesting that a single-threshold management approach may not be ideal...
  15. ncbi request reprint Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries
    Jay L Xue
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:1299-306. 2007
    ..Minority women especially are at greater risk for ESRD than white women. Further studies are needed to determine whether earlier initiation of dialysis is a factor in higher ESRD incidence among minorities...
  16. ncbi request reprint Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001
    Haifeng Guo
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Circulation 115:50-8. 2007
    ..Temporal trends regarding the epidemiology of atherosclerotic renovascular disease (ARVD) in dialysis populations are poorly defined...
  17. ncbi request reprint Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Hemodial Int 11:333-9. 2007
    ..Exceeding hemoglobin level targets has become widespread in the United States and is associated with changes in epoetin dosing practices...
  18. ncbi request reprint Anemia and cost in Medicare patients with congestive heart failure
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minnesota, Minneapolis, MN 55404, USA
    Congest Heart Fail 12:302-6. 2006
    ..25 (95% confidence interval, 1.2546-1.2548). Anemia, a common association of CHF in elderly patients, is an antecedent association of increased societal medical expenditure...
  19. ncbi request reprint Body mass index and survival in peritoneal dialysis patients
    Robert N Foley
    United States Renal Data System, Minneapolis, Minnesota, USA
    Perit Dial Int 25:435-7. 2005
  20. ncbi request reprint Kidney function and sarcopenia in the United States general population: NHANES III
    Robert N Foley
    United States Renal Data System Coordinating Center, Minneapolis, Minn 55404, USA
    Am J Nephrol 27:279-86. 2007
    ..It is not known whether sarcopenia is associated with levels of kidney function in community-dwelling adults...
  21. ncbi request reprint Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 22:2247-55. 2007
    ..We aimed to determine if time required to reach 11 g/dl was associated with increased risk of hospitalization or death among incident dialysis patients...
  22. pmc Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
    ....
  23. ncbi request reprint Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
    ..We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations...
  24. pmc Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
    ..4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I), 18.3%; intermediate-high (I-H), 31.7%, and low-high (L-H), 40.2%...
  25. ncbi request reprint Pneumonia in incident dialysis patients--the United States Renal Data System
    Haifeng Guo
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:680-6. 2008
    ..Although clinical experience suggests that pneumonia may occur frequently in dialysis patients, its clinical epidemiology in that group remains poorly defined...
  26. pmc Mortality trends among Canadian patients receiving dialysis
    Robert N Foley
    Chronic Disease Research Group and the University of Minnesota, Minneapolis, Minn, USA
    CMAJ 177:1055-6. 2007
  27. ncbi request reprint Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Hemodial Int 11:442-7. 2007
    ..8 in 2003). While time to recovery of prehospitalization hemoglobin levels remained constant year to year, epoetin doses and ERI did not, suggesting that optimum perihospitalization anemia management practices have yet to be determined...
  28. ncbi request reprint Infections in patients with chronic kidney disease
    Robert N Foley
    Chronic Disease Research Group, Department of Nephrology, University of Minnesota, 914 South 8th Street, Suite D 206, Minneapolis, MN 55404, USA
    Infect Dis Clin North Am 21:659-72, viii. 2007
    ....
  29. ncbi request reprint Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations
    James P Ebben
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:1205-10. 2006
    ..Hemoglobin levels in almost 90% of patients are in some degree of flux at any point in time, and the fluctuation is highly associated with clinical complications and provider practices...
  30. ncbi request reprint Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures
    Anne M Murray
    Department of Medicine, Geriatrics Division, Hennepin County Medical Center, Minneapolis, MN, USA
    Am J Kidney Dis 50:270-8. 2007
    ..Although cognitive function in hemodialysis patients is believed to be best 24 hours after the dialysis session, the extent of variation during the dialysis cycle is unknown...
  31. ncbi request reprint NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities
    Robert N Foley
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:2575-82. 2007
    ..Defining CKD using a single GFR threshold may be disadvantageous for minority populations because metabolic abnormalities are present at higher levels of GFR...
  32. ncbi request reprint End-stage renal disease in the United States: an update from the United States Renal Data System
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:2644-8. 2007
    ..7% of total Medicare expenditures...
  33. ncbi request reprint Infections and cardiovascular disease in patients with chronic kidney disease
    Robert N Foley
    Chronic Disease Research Group, University of Minnesota, Minneapolis, MN 55404, USA
    Adv Chronic Kidney Dis 13:205-8. 2006
    ..Although recent studies suggest that hospitalization for major infections is much more common in nondialysis CKD than in the general population, the prognostic implications remain unexplored...
  34. ncbi request reprint Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels
    Tricia L Roberts
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, MN 55404, USA
    Nephrol Dial Transplant 21:1652-62. 2006
    ..Thus, integrating factors predictive of anaemia with actual haemoglobin levels might improve prognostic discrimination...
  35. ncbi request reprint Septicemia, access, cardiovascular disease, and death in dialysis patients
    Conall M O'Seaghdha
    Department of Nephrology, Galway Regional Hospitals, Galway, Ireland
    Perit Dial Int 25:534-40. 2005
  36. ncbi request reprint Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States
    Shuling Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 65:1864-9. 2004
    ..The view that hemoglobin levels in peritoneal dialysis patients should be maintained at 11 to 12 g/dL is based largely on the results of studies in hemodialysis patients...
  37. ncbi request reprint Septicemia in the United States dialysis population, 1991 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 206, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 15:1038-45. 2004
    ..7, 2.0, 2.0, and 1.6 after 5 yr, respectively. Septicemia, which is associated with increased cardiovascular and death risk, has become more common in dialysis patients in the United States...
  38. ncbi request reprint Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?
    Areef Ishani
    Department of Medicine, Minneapolis Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota 55417, USA
    Kidney Int 65:1017-25. 2004
    ..We aimed to determine the association between cardioprotective medications and a composite end point of cardiovascular events or death in an incident dialysis cohort...
  39. ncbi request reprint Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    J Am Soc Nephrol 15:174-9. 2004
    ..Hemoglobin levels in U.S. hemodialysis and peritoneal populations are similar. However, erythropoietin doses are dramatically higher in hemodialysis patients...
  40. ncbi request reprint Anaemia and the heart: what's new in 2003?
    Robert N Foley
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Nephrol Dial Transplant 18:viii13-6. 2003
    ..Anaemia may not be an 'innocent bystander' in chronic disease; both components of the term 'anaemia of chronic disease' deserve attention...
  41. ncbi request reprint Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
    ..Being overweight is often cited as a relative contraindication to peritoneal dialysis. Our primary objective was to determine whether actual mortality rates support this opinion...
  42. ncbi request reprint Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure
    Robert N Foley
    Nephrology Analytical Services, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    Semin Dial 16:111-7. 2003
    ..There has been explosive growth in observational studies and a heartening, if less dramatic, increase in risk factor intervention trials, suggesting that risk factor modification can lead to meaningful benefit...
  43. ncbi request reprint Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study
    Robert N Foley
    Cardiovascular Special Studies Center, United States Renal Data System, Minneapolis, Minnesota 55404, USA
    Kidney Int 63:1462-7. 2003
    ..Smoking has received surprisingly little research attention in dialysis populations, a group at monumental cardiovascular risk...
  44. ncbi request reprint A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease
    Julian R Wright
    Department of Renal Medicine, Hope Hospital, Salford, UK
    Am J Kidney Dis 39:1153-61. 2002
    ....
  45. ncbi request reprint Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients
    Suying Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA
    Int Urol Nephrol 35:399-405. 2003
    ..Few studies have assessed treatable factors associated with achieving the Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline of hemoglobin values of 11 to 12 g/dL in anemic hemodialysis patients...
  46. ncbi request reprint Comparing the incomparable: hemodialysis versus peritoneal dialysis in observational studies
    Robert N Foley
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    Perit Dial Int 24:217-21. 2004
    ..Finally, comparisons are complicated by hazards ratios that vary over time, and time-segmented analysis is obligatory. Many types of analytical approaches are needed to begin to appreciate outcome disparities between dialysis therapies...
  47. ncbi request reprint Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients?
    Robert N Foley
    Nephrology Analytical Services, Minneapolis Medical Research Foundation and the Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    Semin Dial 17:275-8. 2004
    ..A large burden of cardiac disease and insensitive analytical approaches may go a long way toward explaining the reverse epidemiology of hypertension and survival in dialysis patients...
  48. ncbi request reprint Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease
    Robert N Foley
    Nephrology Analytical Services, Chronic Disease Research Group, Minneapolis Medical Research Foundation and University of Minnesota, Minneapolis, Minnesota, USA
    Rev Cardiovasc Med 6:S27-34. 2005
    ..Several clinical trials have addressed the hypothesis that darbepoetin alfa can effectively treat renal anemia at dose frequencies of once per week, or less often, with positive outcomes...
  49. ncbi request reprint The unrecognized prevalence of chronic kidney disease in diabetes
    Rachel J Middleton
    Department of Renal Medicine, Hope Hospital, Stott Lane, Salford M6 8HD, UK, and Chronic Disease Research Group and University of Minnesota, Minneapolis, USA
    Nephrol Dial Transplant 21:88-92. 2006
    ..The aim of this study was to estimate the burden of CKD in patients with diabetes and examine the ability of serum creatinine and albuminuria to detect clinically meaningful CKD compared with estimated glomerular filtration rate (eGFR)...
  50. ncbi request reprint Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study
    Robert N Foley
    United States Renal Data System, 914 S 8th St, Suite D253, Minneapolis, MN 55404, USA
    Mayo Clin Proc 80:1270-7. 2005
    ..To determine the prevalence of cardiovascular risk factors in the general population based on kidney function...
  51. ncbi request reprint Anaemia: cardiovascular adaptations and maladaptive responses in chronic kidney disease
    Robert N Foley
    Directorate of Renal Medicine, Hope Hospital, Salford Royal Hospitals NHS Trust, Salford, UK
    Nephrol Dial Transplant 17:32-4. 2002
    ..Whether this strategy, involving efficient surveillance, early detection, early intervention, and high Hb targets that are independent of the phase of CKD, actually reduces cardiac failure or death remains to be seen...
  52. ncbi request reprint Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease
    Shuling Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Int Urol Nephrol 37:395-402. 2005
    ..Large observational studies examining the association between anemia and "hard" clinical outcomes are rare in patients with chronic kidney disease (CKD)...
  53. ncbi request reprint Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis
    Philip A Kalra
    Department of Renal Medicine, Hope Hospital, Salford, United Kingdom
    Kidney Int 68:293-301. 2005
    ..Although atherosclerotic renovascular disease is increasingly recognized in chronic kidney disease, few national level studies have examined its clinical epidemiology...
  54. ncbi request reprint Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
    Patrick S Parfrey
    Division of Nephrology, Health Sciences Center, Memorial University of Newfoundland, Prince Philip Drive, St John s, Newfoundland A1B 3V6, Canada
    J Am Soc Nephrol 16:2180-9. 2005
    ..Normalization of hemoglobin in incident hemodialysis patients does not have a beneficial effect on cardiac structure, compared with partial correction...
  55. ncbi request reprint Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study
    Yelena Slinin
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:1788-93. 2005
    ....
  56. ncbi request reprint First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
    Colin Baigent
    Clinical Trial Service Unit, Oxford University, Oxford, UK
    Am J Kidney Dis 45:473-84. 2005
    ..Patients with chronic kidney disease are at increased risk for cardiovascular disease, but the efficacy and safety of simvastatin and aspirin are unknown in this patient group...
  57. ncbi request reprint Anaemia management and cardiomyopathy in renal failure
    Rosemary L Donne
    Department of Nephrology, Salford Royal Hospitals NHS Trust, Stott Lane, Salford M6 8HD, UK
    Nephrol Dial Transplant 17:37-40. 2002
    ..Ongoing studies should determine whether a physiologically targeted approach to anaemia management reduces the burden of cardiomyopathy in renal failure...